So you can't just put collagen in everything
Graphical Abstract Similar content being viewed by others Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD), with a steady upward trend in prevalence estimates from 25.3% in 19902006 to 38.2% in 20162019 [1], has become a leading cause of chronic liver disease worldwide [2,3,4], increasing the risk of both hepatic and extrahepatic complications, such as cardiovascular and chronic kidney diseases [5, 6]
Once those baseline labs are getting established, so sometimes, you know, with a patient, I'll be like, you got your blood drawn
Others wait weeks and wonder if anything is happening at all
GLP-1 medications offer real benefits for weight and blood sugar management but those benefits should not come at the cost of bone density, muscle function, or immune health
Understanding how retatrutide dosing works is critical for interpreting laboratory and clinical trials exploring its potential role in weight management and diabetes-related research